Literature DB >> 8043869

Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas.

K Bhatia1, G Spangler, G Gaidano, N Hamdy, R Dalla-Favera, I Magrath.   

Abstract

We have analyzed 30 cases of high- and intermediate-grade acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma (AIDS-NHL) for mutations in the c-myc coding region. In addition, in these same tumors, we have sought the presence of mutations in a regulatory region within the first c-myc intron defined by the binding to a factor that inhibits c-myc transcription (MYC intron factor, or mif). Mutations in the c-myc coding region were present in 10 of 16 small noncleaved cell lymphoma (SNCL), but in only 3 of 14 other histologic subtypes tested (0/3 large non-cleaved cell, 2/8 immunoblastic, and 1/3 anaplastic large cell lymphomas). Nineteen of the AIDS-NHLs analyzed contained a c-myc rearrangement and in 10 of these the c-myc gene was mutated in its coding region. In contrast, we could detect a mutation in the coding region in only 2 of 8 AIDS-NHL without a c-myc rearrangement. Mutations in the mif region were detected in 5 of 16 SNCL. Among AIDS-NHL carrying mutations in the c-myc coding region, only 4 carried mutations in the regulatory region. These results suggest that the mutations in the coding region of the c-myc protein may either be a consequence of the translocations involving c-myc, or may be necessary only in tumors where c-myc is deregulated as a result of a c-myc/lg translocation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043869

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  A conserved element in Myc that negatively regulates its proapoptotic activity.

Authors:  Andreas Herbst; Michael T Hemann; Kathryn A Tworkowski; Simone E Salghetti; Scott W Lowe; William P Tansey
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

3.  Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Authors:  Sietse M Aukema; Markus Kreuz; Christian W Kohler; Maciej Rosolowski; Dirk Hasenclever; Michael Hummel; Ralf Küppers; Dido Lenze; German Ott; Christiane Pott; Julia Richter; Andreas Rosenwald; Monika Szczepanowski; Carsten Schwaenen; Harald Stein; Heiko Trautmann; Swen Wessendorf; Lorenz Trümper; Markus Loeffler; Rainer Spang; Philip M Kluin; Wolfram Klapper; Reiner Siebert
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  Myc: the beauty and the beast.

Authors:  Amanda R Wasylishen; Linda Z Penn
Journal:  Genes Cancer       Date:  2010-06

Review 6.  Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.

Authors:  G Gaidano; A Carbone; R Dalla-Favera
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

7.  CRY2 and FBXL3 Cooperatively Degrade c-MYC.

Authors:  Anne-Laure Huber; Stephanie J Papp; Alanna B Chan; Emma Henriksson; Sabine D Jordan; Anna Kriebs; Madelena Nguyen; Martina Wallace; Zhizhong Li; Christian M Metallo; Katja A Lamia
Journal:  Mol Cell       Date:  2016-11-10       Impact factor: 17.970

8.  Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.

Authors:  S Malempati; D Tibbitts; M Cunningham; Y Akkari; S Olson; G Fan; R C Sears
Journal:  Leukemia       Date:  2006-07-20       Impact factor: 11.528

9.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.

Authors:  R Fulton; R Gallagher; D Crouch; J C Neil
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.